As part of US$ 4.2-bn global deal, P&G to acquire Merck India for Rs 12.9 bn

Mumbai: Procter & Gamble will be acquiring Merck India for Rs 12.9 billion (US$ 195.41 million) as a part of its US$ 4.2 billion global deal.

Glenmark, Helsinn Group tie up for CINV drug sale in India, Nepal

New Delhi: Glenmark Pharmaceuticals has signed a licensing agreement with Helsinn Group to launch Akynzeo drug in India and Nepal, it helps prevent chemo-related nausea and vomitin...

Pharmacies may soon have separate shelf for generics

New Delhi: The Government of India has made it mandatory for pharmacies to keep generic medicines conspicuously on separate shelves from other medicines which will promote consumer...

Government announces launch of 'SUVIDHA' - Rs. 2.50, 100% Oxo-biodegradable Sanitary Napkin - under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

New Delhi: Ministry of Chemicals and Fertilizers has launched 'Suvidha', an affordable and 100% Oxo-biodegradable Sanitary Napkin under the Pradhana Mantri Bhartiya Janaush...

Regulator plans single-window system for new drug approvals

New Delhi: A single-window system for innovators and startups looking for consents, approvals and information has been proposed by the Drug Controller General of India (DCGI) with ...

'India Pharma & India Medical Device 2018': Affordable and Quality Healthcare

New Delhi: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, and Federation of Indian Chambers of Commerce and Industry (FICCI) are jointly organising ‘In...

Domestic pharma gets extended release from low growth

New Delhi: Medicine sales in India increased 8.1 per cent year-on-year in November 2017 on the back of higher volumes, while sustained growth is expected in the next few quarters, ...

Indian healthcare market to hit US$ 372 bn by 2022

New Delhi: Healthcare market in India is expected to increase at a CAGR of 22 per cent to reach US$ 372 billion by 2022 on the back of increasing demand for affordable healthcare, ...